Literature DB >> 11377052

Identification and quantitation of sodium-thyroxine and its degradation products by LC using electrochemical and MS detection.

A G Kazemifard1, D E Moore, A Aghazadeh.   

Abstract

High performance liquid chromatography (HPLC) was used in combination with an amperometric and mass spectrometric detection to elucidate and quantitate the degradation products and contaminants of the photo-sensitive Na-thyroxine. Using HPLC with amperometric detection, seven decomposition compounds were separated. These products, which occur mostly as contaminants, were then identified by a developed liquid chromatography-mass spectrometry technique. The same HPLC method was also employed to analyze Na-thyroxine and its degradation products in three commercially available brands of Na-thyroxine tablets.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377052     DOI: 10.1016/s0731-7085(01)00370-3

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate.

Authors:  Jarrod W Collier; Rakhi B Shah; Abhay Gupta; Vilayat Sayeed; Muhammad J Habib; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2010-05-08       Impact factor: 3.246

2.  Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products.

Authors:  J W Collier; R B Shah; A R Bryant; M J Habib; M A Khan; P J Faustino
Journal:  J Pharm Biomed Anal       Date:  2010-10-13       Impact factor: 3.935

Review 3.  Nano optical and electrochemical sensors and biosensors for detection of narrow therapeutic index drugs.

Authors:  Omid Heydari Shayesteh; Reza Mahjub; Akram Ranjbar; Katayoun Derakhshandeh; Mahdi Jamshidi
Journal:  Mikrochim Acta       Date:  2021-11-06       Impact factor: 5.833

4.  Tablet splitting of a narrow therapeutic index drug: a case with levothyroxine sodium.

Authors:  Rakhi B Shah; Jarrod S Collier; Vilayat A Sayeed; Arthur Bryant; Muhammad J Habib; Mansoor A Khan
Journal:  AAPS PharmSciTech       Date:  2010-08-26       Impact factor: 3.246

5.  TSH-based protocol, tablet instability, and absorption effects on L-T4 bioequivalence.

Authors:  Marisa Eisenberg; Joseph J Distefano
Journal:  Thyroid       Date:  2009-02       Impact factor: 6.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.